Overview
Sumiyuki Nishida practices in Suita, Japan. Nishida is rated as a Distinguished expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Their top areas of expertise are Wilms Tumor, WT1-Related Wilms Tumor Syndromes, Renal Cell Carcinoma (RCC), and Thymic Epithelial Tumor.
Their clinical research consists of co-authoring 151 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of WT1-Related Wilms Tumor Syndromes.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Wilms TumorNishida isDistinguished. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesNishida isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Experienced
- Castleman DiseaseNishida isExperienced. Learn about Castleman Disease.
- Chronic Myelogenous Leukemia (CML)
- Infantile NeutropeniaNishida isExperienced. Learn about Infantile Neutropenia.
- LeukemiaNishida isExperienced. Learn about Leukemia.
- Lung CancerNishida isExperienced. Learn about Lung Cancer.
- Lymphoid HyperplasiaNishida isExperienced. Learn about Lymphoid Hyperplasia.